Riskpilot← Back to searchSign inGet full accessMARIKOLLEN TORG APOTEK AS
ASActiveOrg 927365596Tangerudvegen 1, 2008 FjerdingbyRetail sale of pharmaceutical products · NACE 4773Est. 202113 employees
Revenue 2025
NOK 20,8M
+20% vs 2024
EBITDA margin
4.9%
+29% vs 2024
Equity ratio
27.4%
Financial strength
Net profit 2025
NOK 625K
+63% vs 2024
| Revenue | NOK 20,8M | +20% |
| EBITDA | NOK 1M | +29% |
| Net profit | NOK 625K | +63% |
| Total assets | NOK 4,8M | +33% |
| Equity | NOK 1,3M | +47% |
| Employees | 13 | — |
Legal name
MARIKOLLEN TORG APOTEK AS
Org number
927365596
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
1. juli 2021
Share capital
NOK 66 000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Address
Tangerudvegen 1, 2008 Fjerdingby
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 5 211 | 12 123 | 17 411 | 20 822 |
| Staff expenses | −0 | −1 779 | −2 117 | −2 577 | −2 875 |
| EBITDA | −7 | −599 | 330 | 783 | 1 012 |
| Depreciation & amort. | −1 | −127 | −208 | −208 | −208 |
| EBIT | −7 | −726 | 122 | 574 | 804 |
| Net financials | 0 | −69 | −103 | −83 | −3 |
| Profit before tax | −7 | −795 | 19 | 492 | 801 |
| Tax | −4 | −175 | 4 | 108 | 176 |
| Net profit | −3 | −620 | 14 | 383 | 625 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 41 | 3 623 | 5 232 | 3 627 | 4 824 |
| Equity | 16 | −103 | 511 | 895 | 1 320 |
| Long-term debt | 0 | 1 590 | 1 230 | 387 | 0 |
| Short-term debt | 25 | 2 136 | 3 491 | 2 346 | 3 488 |
| Total debt | 25 | 3 726 | 4 721 | 2 733 | 3 504 |
EBITDA margin
4.9%
This company
15.8%
Market median
-69% vs market
20212025
Equity ratio
27.4%
This company
38.2%
Market median
-28% vs market
20212025
Return on equity
47.3%
This company
18.4%
Market median
+157% vs market
20212025
Net profit margin
3.0%
This company
8.1%
Market median
-63% vs market
20212025
Asset turnover
4.32×
This company
1.12×
Market median
+286% vs market
20212025
Debt / equity
2.66×
This company
0.62×
Market median
-329% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-06-02 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AB Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Apoinvest Holding As
MARIKOLLEN TORG APOTEK AS Board members of MARIKOLLEN TORG APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Brekke | Chief Executive Officer | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Chairman | 0 companies |
| Gulzeb Aziz | Board of Directors | 0 companies |